A peer reviewed article by Ashlan J. Kunz Coyne, PharmD, MPH, Elaine M. Bailey, PharmD, and Erinne Kennedy, DMD, MPH, MMSc
Although almost 10% of the US population reports an allergy to penicillin (PCN), most of these patients are not truly allergic. There are well-defined harms associated with unverified PCN allergies including ineffective treatment, overtreatment, and more broad-spectrum treatment that results in antibiotic resistance and adverse effects including Clostridioides difficile infection. For these reasons, the health-care community should screen and evaluate PCN allergies to ensure that patients receive first-line antibiotics whenever possible. The dental office provides an opportunity to practice PCN allergy stewardship, with the goal of increasing the proportion of patients receiving first-line antibiotic therapy. Tools to support the involvement of the dental team in assisting patients to navigate the reassessment of their allergy labels will be demonstrated.
Educational objectives
At the conclusion of this educational activity, participants will be able to:
- Discuss the potential consequences of prescribing second-line antibiotic therapies in patients who report a penicillin allergy
- Describe clinical scenarios in which a patient may be mislabeled as being allergic to penicillin
- Determine how to implement chairside tools designed to identify patients who may benefit from a reassessment of their penicillin allergy
- Communicate to the patient the process for penicillin allergy reassessment, including removal of the penicillin allergy label from their medical/dental record(s)
Image credit: Doucefleur / iStock / Getty Images Plus via Getty Images
Quick Access Code: 22451
Course Content



